Literature DB >> 10780330

ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden.

A Robert, M F Aillaud, V Eschwège, A Randrianjohany, Y Scarabin, I Juhan-Vague.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10780330

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.

Authors:  Armelle Poujol-Robert; Pierre-Yves Boëlle; Dominique Wendum; Raoul Poupon; Annie Robert
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

2.  Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies.

Authors:  Brian M Wolpin; Christopher Kabrhel; Raphaëlle Varraso; Peter Kraft; Eric B Rimm; Samuel Z Goldhaber; Carlos A Camargo; Charles S Fuchs
Journal:  Thromb Haemost       Date:  2010-09-30       Impact factor: 5.249

3.  ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia.

Authors:  Luca Spiezia; Elena Campello; Maria Bon; Tiziana Tison; Marta Milan; Paolo Simioni; Paolo Prandoni
Journal:  Blood Transfus       Date:  2012-10-11       Impact factor: 3.443

4.  The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection.

Authors:  Ahmad Shavakhi; Mehri Hajalikhani; Mohammad Minakari; Alireza Norian; Rahil Riahi; Mina Azarnia; Lida Liaghat
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

5.  Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population.

Authors:  Magaly B P L V Lima; Aldemir Branco de Oliveira-Filho; Júlia F Campos; Fárida C B C Melo; Washington Batista das Neves; Raul Antônio Morais Melo; José Alexandre Rodrigues Lemos
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.